SfN's 48th Annual Meeting, Neuroscience 2018, is the world's largest neuroscience conference for scientists & physicians devoted to understanding the brain and nervous system.
This conference saw neuroscientists collaborate and network with peers, talks from experts, all exploring the newest neuroscience tools and technologies.
Attended were 30,000 delegates from more than 80 countries at the world’s largest marketplace of ideas and tools for global neuroscience.
Our symposium was entitled 'Novel Research Models and Their Utility In Studying Human Neurological Disease'.
In understanding neurological disease such as Parkinson’s, Alzheimer’s, Autism, or Pain, ideal research models are heavily relied upon for developing new discoveries with disease progression and mimicking human disease phenotypes. Identifying the ideal model for your research is crucial in many ways. During this symposium our key speakers will be presenting in depth analysis of their Neuroscience research and how they have utilized ideal animal models generated by nuclease technology.
Dr. David Wyllie, Director, Centre for Discovery Brain Sciences, The University of Edinburgh, Edinburgh, UK will be presenting a talk entitled 'Using rat models to understand physiological dysfunction in autism and intellectual disability'. David's presentation will review his recent studies of rat models of autism spectrum disorder and intellectual disability, highlighting where divergent genetic causes of autism and intellectual disability show convergence in their (patho) physiological phenotypes.
Speakers also presenting at this symposium were from the Center for Translational NeuroImaging at Northeastern University, and Dr Zhenyi Liu (Horizon Discovery, Principle Scientist).
When: November 5
Time and location: 18:30 – 21:30, Hilton San Diego Bayfront, Indigo Ballroom D
Throughout the meeting, we held Tech Talks at our stand, 3416 entitled:
'Humanized ApoE Rat Lines and Isolated Neurons'
'Developing a rat genetic toolbox for optogenetics'
We also presented posters on our latest R&D project